LUCINAE Registry: Thoracic Cancers During Pregnancy
- Sponsor
- Oncology Institute of Southern Switzerland
- Study ID
- NCT07699861
- Status
- Recruiting
Conditions
- Cancer During Pregnancy
- Lung Cancer
- Thoracic Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The LUCINAE Registry is an international, multicenter observational study collecting data on patients with thoracic cancers (including lung cancer) who are expecting a child. This includes women diagnosed during pregnancy, women who become pregnant during or after cancer, and men receiving cancer treatment at the time their partner conceives. Because thoracic cancers during pregnancy are rare, there is limited information to guide clinical decisions. This registry aims to describe patient characteristics, diagnostic approaches, treatments, and maternal and fetal outcomes. Data are collected retrospectively and prospectively from participating centers. The results of this registry are expected to improve understanding of thoracic cancers in this setting and support the development of future clinical recommendations.
Key Dates
- First listed
- Jul 13, 2026
- Start date
- Jun 30, 2026
- Status verified
- Jul 2026
- Primary completion
- Dec 31, 2035
- Completion
- Dec 31, 2035
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Cohort ARetrospective patients: patients who are included in the registry only after death.
- Arm: Cohort BProspective patients: patients who are currently treated at the participating site or will be diagnosed during the enrollment
Primary Outcome Measure
Timing of diagnosis [ Time Frame: At the moment of patient enrolment ]
Central Contacts
- Martina Imbimbo+41918119631
- Luigi Tortola+41 91 811 96 68
Find similar trials
Related Studies
- Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Detection of Genetic Markers of Lung CancerRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Lung Cancer Biomarkers and ScreeningRecruiting · NYU Langone Health · New York, New York